Full Study Title: Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients
Principal Investigators: Marc Carrier, Phil Wells
Funding: CIHR (Canadian Institutes of Health Research), BMS (BMS Pfizer (Bristol-Myers Squibb Pfizer)
For more information: NCT02048865 https://clinicaltrials.gov/
Publication: https://www.nejm.org/doi/full/10.1056/NEJMoa1814468
Full Study Title: Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban
Principal Investigator: Michael J. Kovacs
Study Publication: http://www.sciencedirect.com/science/article/pii/S0049384817302578?via%3Dihub
Full Study Title: Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty
Principal Investigator: David Anderson
Funding: CIHR (Canadian Institutes of Health Research)
Design: Double-blind RCT (randomized clinical trial) of rivaroxaban vs. aspirin for total knee and total hip arthroplasty
For more information: NCT01720108 https://clinicaltrials.gov/
Study Publication: http://www.nejm.org/doi/full/10.1056/NEJMoa1712746
Full Study Title: Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Principal Investigator: Marc Rodger
Funding: Funded by a grant from the French Ministry of Health (PHRC 2009-08-05) and BioMerieux
Study Publication: http://www.bmj.com/content/356/bmj.j1065
Full Study Title: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Principal Investigator: Sam Schulman
Funding: Octapharma
Study Publication (Abstract): https://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1636541